Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristina Lorenz

Showing results (1-10 of 90) with videos related to

Pageof 9
Sort By:
Naunyn-Schmiedeberg'S Archives of Pharmacology|October 13, 2025
Finn Waagstein and the paradigm shift in the treatment of heart failure with β-adrenergic receptor antagonists ('β-blockers')Kristina Lorenz, Ursula Ravens
Cancers|February 25, 2022
Harnessing RKIP to Combat Heart Disease and CancerKristina Lorenz, Marsha Rich Rosner
Critical Reviews in Oncogenesis|January 20, 2015
RKIP: a governor of intracellular signalingKristina Lorenz, Evelyn Schmid, Katharina Deiss
International Journal of Molecular Sciences|May 5, 2019
How to Steer and Control ERK and the ERK Signaling Cascade Exemplified by Looking at Cardiac InsufficiencyTim Breitenbach, Kristina Lorenz, Thomas Dandekar
Plos One|August 30, 2018
The A2B adenosine receptor in MDA-MB-231 breast cancer cells diminishes ERK1/2 phosphorylation by activation of MAPK-phosphatase-1Marthe Koussémou, Kristina Lorenz, Karl-Norbert Klotz
Nature|December 5, 2003
Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2Kristina Lorenz, Martin J Lohse, Ursula Quitterer
Molecular Aspects of Medicine|August 22, 2018
Oxidation of cardiac myofilament proteins: Priming for dysfunction?Friederike Cuello, Ilka Wittig, Kristina Lorenz, et al.
Biochemical and Biophysical Research Communications|October 13, 2019
The N-termini of GRK2 and GRK3 simulate the stimulating effects of RKIP on β-adrenoceptorsTheopisti Maimari, Cornelius Krasel, Moritz Bünemann, et al.
The Journal of Biological Chemistry|May 22, 2012
Raf kinase inhibitor protein (RKIP) dimer formation controls its target switch from Raf1 to G protein-coupled receptor kinase (GRK) 2Katharina Deiss, Caroline Kisker, Martin J Lohse, et al.
The Journal of Biological Chemistry|January 7, 2005
Beta-arrestin binding to the beta2-adrenergic receptor requires both receptor phosphorylation and receptor activationCornelius Krasel, Moritz Bünemann, Kristina Lorenz, et al.
Pageof 9

Showing results (1-10 of 90) with videos related to

Sort By:
Pageof 9
Naunyn-Schmiedeberg'S Archives of Pharmacology|October 13, 2025
Finn Waagstein and the paradigm shift in the treatment of heart failure with β-adrenergic receptor antagonists ('β-blockers')Kristina Lorenz, Ursula Ravens
Cancers|February 25, 2022
Harnessing RKIP to Combat Heart Disease and CancerKristina Lorenz, Marsha Rich Rosner
Critical Reviews in Oncogenesis|January 20, 2015
RKIP: a governor of intracellular signalingKristina Lorenz, Evelyn Schmid, Katharina Deiss
International Journal of Molecular Sciences|May 5, 2019
How to Steer and Control ERK and the ERK Signaling Cascade Exemplified by Looking at Cardiac InsufficiencyTim Breitenbach, Kristina Lorenz, Thomas Dandekar
Plos One|August 30, 2018
The A2B adenosine receptor in MDA-MB-231 breast cancer cells diminishes ERK1/2 phosphorylation by activation of MAPK-phosphatase-1Marthe Koussémou, Kristina Lorenz, Karl-Norbert Klotz
Nature|December 5, 2003
Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2Kristina Lorenz, Martin J Lohse, Ursula Quitterer
Molecular Aspects of Medicine|August 22, 2018
Oxidation of cardiac myofilament proteins: Priming for dysfunction?Friederike Cuello, Ilka Wittig, Kristina Lorenz, et al.
Biochemical and Biophysical Research Communications|October 13, 2019
The N-termini of GRK2 and GRK3 simulate the stimulating effects of RKIP on β-adrenoceptorsTheopisti Maimari, Cornelius Krasel, Moritz Bünemann, et al.
The Journal of Biological Chemistry|May 22, 2012
Raf kinase inhibitor protein (RKIP) dimer formation controls its target switch from Raf1 to G protein-coupled receptor kinase (GRK) 2Katharina Deiss, Caroline Kisker, Martin J Lohse, et al.
The Journal of Biological Chemistry|January 7, 2005
Beta-arrestin binding to the beta2-adrenergic receptor requires both receptor phosphorylation and receptor activationCornelius Krasel, Moritz Bünemann, Kristina Lorenz, et al.
Pageof 9